Show simple item record

dc.contributor.authorAldrich, Jane V.
dc.contributor.authorMcLaughlin, Jay P.
dc.date.accessioned2017-03-08T20:11:36Z
dc.date.available2017-03-08T20:11:36Z
dc.date.issued2013-04-01
dc.identifier.citationAldrich, Jane V., and Jay P. Mclaughlin. "Opioid Peptides: Potential for Drug Development." Drug Discovery Today: Technologies 9.1 (2012): n. pag.en_US
dc.identifier.urihttp://hdl.handle.net/1808/23368
dc.description.abstractOpioid receptors are important targets for the treatment of pain and potentially for other disease states (e.g. mood disorders and drug abuse) as well. Significant recent advances have been made in identifying opioid peptide analogs that exhibit promising in vivo activity for treatment of these maladies. This review focuses on the development and evaluation of opioid peptide analogs demonstrating activity after systemic administration, and recent clinical evaluations of opioid peptides for possible therapeutic use.en_US
dc.publisherElsevieren_US
dc.rightsThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.en_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/
dc.titleOpioid Peptides: Potential for Drug Developmenten_US
dc.typeArticleen_US
kusw.kuauthorAldrich, Jane V.
kusw.kudepartmentPharmaceutical Chemistryen_US
dc.identifier.doi10.1016/j.ddtec.2011.07.007en_US
kusw.oaversionScholarly/refereed, author accepted manuscripten_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Except where otherwise noted, this item's license is described as: This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License 3.0 (CC BY-NC-ND 3.0 US), which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.